Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

White Papers and Resources

Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.

- PMLiVE

Teeing Off with the Masters: Lessons for Brands Inspired by Golf’s Biggest Event

September 27, 2024 |  White Papers and Resources  |

Highly encouraged to read this in Jim Nantz voice Hello friends. Consider a brand. Picture an experience. The Masters, one of the world’s most esteemed …

Read More

Brought to you by  CMI Media Group 

- PMLiVE

Supporting Blood Cancer Patients: The Importance of Patient-Centric Pharma Campaigns

September 27, 2024 |  White Papers and Resources  |

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, understanding, and support for those living with blood …

Read More

Brought to you by  Mednet 

- PMLiVE

Championing people-powered communications in rare diseases: AMICULUM’s feature in The Guardian Rare Diseases Campaign 2024

September 26, 2024 |  White Papers and Resources  |

By Ellie Thomas

Read More

Brought to you by  Amiculum 

- PMLiVE

AI in market access: silver bullet or spanner in the works?

September 25, 2024 |  White Papers and Resources  |

By Emily Morton-West

Read More

Brought to you by  Amiculum 

- PMLiVE

What is willingness to pay? – Comparing price testing methodologies

September 24, 2024 |  White Papers and Resources  |

Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech …

Read More

Brought to you by  Petauri Evidence 

- PMLiVE

Where did “KOLs” come from, and why do they matter?

September 19, 2024 |  White Papers and Resources  |

Ever wondered where ‘KOLs’ came from and why they matter? Dr Alex Loveday answers those questions in this latest edition of her column.

Read More

Brought to you by  Mednet 

- PMLiVE

Evolving market access pathways for AI-enabled Medtech in Europe

September 17, 2024 |  White Papers and Resources  |

Louise Maddison (Senior Consultant – Global Market Access, Mtech Access) explores the evolving market access landscape for AI-enabled Medtech, with a particular focus on the …

Read More

Brought to you by  Petauri Evidence 

- PMLiVE

Answering some of Pharma’s big questions to drive brand strategies

September 12, 2024 |  White Papers and Resources  |

By James Aird and Zoë van Helmond

Read More

Brought to you by  Amiculum 

- PMLiVE

What are “orphan drugs” and how do we navigate the challenges of writing about them?

September 6, 2024 |  White Papers and Resources  |

The first in our ‘Ask Alex’ series, where Principal Medical Writer, Dr Alexandra Loveday answers some frequently asked questions about Medcomms. This week, she takes …

Read More

Brought to you by  Mednet 

- PMLiVE

Unlocking market access success for cell and gene therapies: the vital role of early strategic planning

September 5, 2024 |  White Papers and Resources  |

By Manca Povsic

Read More

Brought to you by  Amiculum 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links